GSA CAPITAL PARTNERS LLP - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 131 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q1 2023$691
+297.1%
28,827
+180.4%
0.07%
+209.1%
Q4 2022$174
-100.0%
10,281
-80.2%
0.02%
-82.0%
Q2 2022$816,000
+272.6%
51,848
+876.2%
0.12%
+238.9%
Q1 2021$219,000
-22.3%
5,311
-18.4%
0.04%
-21.7%
Q4 2020$282,0006,5110.05%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q2 2022
NameSharesValueWeighting ↓
Tri Locum Partners LP 208,886$5,337,0371.71%
Portolan Capital Management 276,505$7,064,7030.66%
Nikko Asset Management Americas, Inc. 1,388,574$35,422,5230.42%
Green Alpha Advisors, LLC 21,538$550,2960.42%
SummerHaven Investment Management, LLC 22,326$570,4290.42%
ARK Investment Management 1,901,546$48,584,5080.37%
Granahan Investment Management 398,862$10,190,9240.36%
FEDERATED HERMES, INC. 4,711,512$120,379,1320.32%
Woodline Partners LP 1,069,814$27,333,7480.32%
Diametric Capital, LP 26,130$667,6210.28%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders